Physician

Kurt R Oelke, M.D.

According to 2025 Medicare claims, Kurt Oelke, M.D. (NPI: 1962433136) practices rheumatology in the Milwaukee-Waukesha, WI market, with the plurality of this provider's patient population coming from Ozaukee, WI. This provider's primary affiliated billing organization is RHEUMATIC DISEASE CENTER (NPI: 1609812544; TIN: 391713075) and primary practice location at 53217-3879.

Oelke's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 277 traditional Medicare patients, billed 100,303 HCPCS/CPT codes, and received $1,280,862 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,660 prescription claims across 614 beneficiaries totaling $2,688,344 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 218 records totaling $270,602. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $975,266 to $2,688,344. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	386	38,861	$962,526
2016	369	45,524	$1,114,077
2017	364	63,113	$1,297,254
2018	357	70,205	$1,620,313
2019	369	65,530	$1,558,002
2020	341	72,394	$1,463,785
2021	335	68,756	$1,269,842
2022	337	75,350	$1,121,980
2023	295	92,306	$1,215,870
2024	277	100,303	$1,280,862

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	475	4,895	$975,266
2016	473	4,537	$1,099,462
2017	499	4,450	$1,396,332
2018	494	4,310	$1,540,297
2019	492	4,249	$1,779,711
2020	511	4,281	$1,671,710
2021	554	4,447	$1,756,214
2022	613	4,691	$2,132,270
2023	625	4,855	$2,439,160
2024	614	4,660	$2,688,344

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	207	353	$87
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	207	288	$12
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	101	177	$8
84460	Liver enzyme (sgpt), level	98	176	$5
82565	Blood creatinine level	98	165	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	72	2,044	$492,351
Rinvoq	Upadacitinib	71	2,130	$484,448
Xeljanz	Tofacitinib Citrate	40	1,440	$277,678
Enbrel Sureclick	Etanercept	31	952	$248,028
Enbrel	Etanercept	29	812	$208,904

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	205	$96,562	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	13	$174,040	E.R. Squibb & Sons, L.L.C.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kurt R. Oelke, M.D.?

Tedicare shows public-source Medicare data for Kurt R. Oelke, M.D. (NPI 1962433136), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kurt R. Oelke, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kurt R. Oelke, M.D.?

Kurt R. Oelke, M.D. is linked to RHEUMATIC DISEASE CENTER (billing NPI 1609812544) in the available physician profile data.

Does Kurt R. Oelke, M.D. have Open Payments data?

Kurt R. Oelke, M.D. has 218 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.